Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida
ZURICH (Reuters) -Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a specialist in complex immune cell...